Related Experiment Videos
Atypical pneumonia: recognition and treatment
Abstract:
While the term "atypical pneumonia" has been in use for many years, it cannot in fact be defined. However, there is a persuasive reason to retain the clinical use of the term, and that is to provide a guide for the clinician in the choice of empirical antibiotic therapy for patients with acute pneumonia. Atypical pneumonia, then, is a descriptive term for a common clinical syndrome. Provided certain clinicoepidemiological groups are excluded, the most common infectious causes of this syndrome are Mycoplasma pneumoniae, Chlamydia psittaci, Coxiella burneti, and Legionella species, but it should be stressed that the syndrome may occasionally be produced by other infectious and non-infectious diseases. Conversely, the atypical pneumonia syndrome occupies only one part of the clinical spectrum of disease that is caused by these organisms. This becomes important when one is selecting antibiotic therapy for patients with other respiratory syndromes, especially those with life-threatening disease. The antimicrobial therapy of the three common causes of atypical pneumonia is discussed in detail.
Insights
The term "atypical pneumonia" guides antibiotic choices for acute pneumonia, despite lacking a strict definition. Common causes include Mycoplasma pneumoniae and Legionella species, guiding empirical therapy.
Area of Science:
- Infectious Diseases
- Pulmonology
- Clinical Microbiology
Background:
- The term 'atypical pneumonia' is clinically useful for guiding empirical antibiotic therapy.
- It describes a common syndrome, though not strictly definable.
- Understanding common causative agents is crucial for effective treatment.
Purpose of the Study:
- To emphasize the clinical utility of the term 'atypical pneumonia'.
- To identify the most common infectious agents causing this syndrome.
- To discuss the antimicrobial therapy for prevalent causes of atypical pneumonia.
Main Methods:
- Clinical and epidemiological review of 'atypical pneumonia' syndrome.
- Identification of common causative microorganisms.
- Detailed discussion of antimicrobial treatment strategies.
Main Results:
- Mycoplasma pneumoniae, Chlamydia psittaci, Coxiella burneti, and Legionella species are the most frequent infectious causes.
- The syndrome can occasionally result from other infectious or non-infectious diseases.
- The clinical spectrum of these organisms extends beyond the 'atypical pneumonia' syndrome.
Conclusions:
- The term 'atypical pneumonia' remains a valuable clinical descriptor for guiding initial antibiotic selection.
- Knowledge of specific causative agents and their broader disease spectrum is essential for optimizing therapy, especially in severe cases.
- Antimicrobial therapy for common causes like Mycoplasma pneumoniae is detailed.